NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Back to Agenda

Session 6 : Development of Innovative Drug

Session Chair(s)

Heesung Kim, PHD

Director of Pre-Submission Consultation Division, NIFDS, MFDS, Korea, Republic of

Speaker(s)

Jun Park, PHD

EVP/Chief Technology Officer, ILIAS Biologics, Inc., Korea, Republic of

Hae-Young Ahn, PHD

President, Ahn Bio, United States

Youngju Choi, PHD

Director General of Biopharmaceutical & Herbal Medicine Evaluation Department , National Institute of Food & Drug Safety (NIFDS), MFDS, Korea, Republic of

Have an account?